Biomarkers and prognostic factors for mesothelioma

Por Pass, Harvey I.
Publicado em 2012

Translation research: from accurate diagnosis to appropriate treatment

Por Pass Harvey I, Webb Craig P
Publicado em 2004-10-01

Translation research: from accurate diagnosis to appropriate treatment

Por Webb, Craig P, Pass, Harvey I
Publicado em 2004

Malignant mesothelioma advances in pathogenesis, diagnosis, and translational therapies /

Por Pass, Harvey I., Vogelzang, Nicholas J., Carbone, Michele.
Publicado em 2005

Diagnosis and prognosis—review of biomarkers for mesothelioma

Por Sun, Huan H., Vaynblat, Allen, Pass, Harvey I.
Publicado no Ann Transl Med (2017)

Treatment of recalcitrant subcutaneous emphysema using negative pressure wound therapy dressings

Por Towe, Christopher, Solomon, Brian, Donington, Jessica S, Pass, Harvey I
Publicado no BMJ Case Rep (2014)

Lung Cancer Osteopontin Isoforms Exhibit Angiogenic Functional Heterogeneity

Por Blasberg, Justin D., Goparaju, Chandra M., Pass, Harvey I., Donington, Jessica S.
Publicado em 2009

Latest developments in our understanding of the pathogenesis of mesothelioma and the design of targeted therapies

Por Bononi, Angela, Napolitano, Andrea, Pass, Harvey I, Yang, Haining, Carbone, Michele
Publicado no Expert Rev Respir Med (2015)

Diagnostic and prognostic biomarkers for malignant mesothelioma: an update

Por Chen, Zhongjian, Gaudino, Giovanni, Pass, Harvey I., Carbone, Michele, Yang, Haining
Publicado no Transl Lung Cancer Res (2017)

BAP1 and Cancer

Por Carbone, Michele, Yang, Haining, Pass, Harvey I., Krausz, Thomas, Testa, Joseph R., Gaudino, Giovanni
Publicado em 2013

MicroRNAs derived from circulating exosomes as non-invasive biomarkers for screening and diagnose lung cancer

Por Cazzoli, Riccardo, Buttitta, Fiamma, Di Nicola, Marta, Malatesta, Sara, Marchetti, Antonio, Pass, Harvey I.
Publicado em 2013

A STAT3-NFkB/DDIT3/CEBPβ axis modulates ALDH1A3 expression in chemoresistant cell subpopulations

Por Canino, Claudia, Luo, YuYing, Marcato, Paola, Blandino, Giovanni, Pass, Harvey I., Cioce, Mario
Publicado no Oncotarget (2015)

Exosomal miR-16-5p as a target for malignant mesothelioma

Por Munson, Phillip B., Hall, Elizabeth M., Farina, Nicholas H., Pass, Harvey I., Shukla, Arti
Publicado no Sci Rep (2019)

The promyelocytic leukemia zinc finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival

Por Cheung, Mitchell, Pei, Jianming, Pei, Yaguang, Jhanwar, Suresh C., Pass, Harvey I., Testa, Joseph R.
Publicado em 2009

Nuclear, compared with combined nuclear and cytoplasmic expression of maspin, is linked in lung adenocarcinoma to reduced VEGF-A levels and in Stage I, improved survival

Por Frey, Amy, Soubani, Ayman O, Adam, Abdulgadir K, Sheng, Shijie, Pass, Harvey I, Lonardo, Fulvio
Publicado em 2009

Positive nuclear BAP1 immunostaining helps differentiate non-small cell lung carcinomas from malignant mesothelioma

Por Carbone, Michele, Shimizu, David, Napolitano, Andrea, Tanji, Mika, Pass, Harvey I., Yang, Haining, Pastorino, Sandra
Publicado no Oncotarget (2016)

Clinical validation of a blood-based classifier for diagnostic evaluation of asymptomatic individuals with pulmonary nodules

Por Birse, Charles E., Tomic, Jennifer L., Pass, Harvey I., Rom, William N., Lagier, Robert J.
Publicado no Clin Proteomics (2017)

Association of Asbestos Exposure With Malignant Mesothelioma Incidence in Eastern China

Por Mao, Weimin, Zhang, Xing, Guo, Zhenying, Gao, Zhibin, Pass, Harvey I., Yang, Haining, Carbone, Michele
Publicado no JAMA Oncol (2017)

The microbiome in lung cancer tissue and recurrence-free survival

Por Peters, Brandilyn A., Hayes, Richard B., Goparaju, Chandra, Reid, Christopher, Pass, Harvey I., Ahn, Jiyoung
Publicado no Cancer Epidemiol Biomarkers Prev (2019)

Reduction of Elevated Plasma Osteopontin Levels With Resection of Non–Small-Cell Lung Cancer

Por Blasberg, Justin D., Pass, Harvey I., Goparaju, Chandra M., Flores, Raja M., Lee, Suzie, Donington, Jessica S.
Publicado em 2010